Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Very few of us use the word wellness to mean the same thing twice. Before a big illness, before divorce, before being laid-off, before their addiction — ask somebody what wellness meant — it was typically a gym membership with an accompanying green juice and perhaps even a step-counter. Ask again after. Your answer is […]

The post How People Redefine Wellness After Facing Significant Personal Challenges appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Red light therapy has moved from exclusive clinics to everyday homes. The photobiomodulation technology trend attracts people who want gentle health solutions. Is it safe? How do you pick a device? We cover everything in this blog to help you pick the right home device. Understand Photobiomodulation The scientific name of red light therapy is […]

The post Understanding Red Light Therapy: Science, Safety and the Future of Home Wellness appeared first on Medical News Bulletin.

Healio LIVE and Healio AI announced a partnership that will increase Healio AI’s access to educational programming, strengthening the HIPAA-compliant platform’s knowledge base, according to a press release.
The collaboration between Healio LIVE, which organizes live CME conferences, and Healio AI, which generates evidence-based responses to clinical questions, will provide relevant, critical and actionable insights to practicing clinicians and healthcare professionals (HCPs), according to the release.
“With this partnership, Healio AI is bridging the gap between the latest clinical information

The FDA has expanded a safety alert warning consumers to avoid certain botanical weight loss supplements that contain toxic yellow oleander.
Analysis showed three additional online products labeled as tejocote (Crataegus mexicana) root or Brazil seed instead contained yellow oleander (Thevetia peruviana) — a toxic plant native to Mexico and Central America.
According to the FDA, these products can cause neurologic, gastrointestinal and cardiovascular adverse events that could be severe or fatal.
The agency advises consumers to stop using and dispose of these products. Those who have used any of

Several states have introduced legislation that would establish new reporting and data-collection requirements for assisted reproductive technology, raising questions about how the measures could affect fertility care, according to experts.
Christopher P. Moutos, MD, a physician member of the American Society for Reproductive Medicine, and colleagues published an article in The New England Journal of Medicine that describes what they call “an emerging threat” in the U.S.
Just last year, Arkansas enacted a restorative reproductive medicine (RRM) law, becoming the first U.S. state to do so,

Double lung transplant conferred favorable early outcomes among a select group of adults with stage IV non-small cell lung cancer and respiratory failure, according to study results.
All 17 patients who met strict criteria and underwent transplant remained alive at 1 year. In contrast, fewer than half of adults with similar disease characteristics who received medical management — such as chemotherapy, radiation or immunotherapy — lived that long.
Post-transplant survival also appeared comparable between transplant recipients with NSCLC and those who underwent transplant for noncancer

PHOENIX — Results presented here showed residual quadriceps weakness in young athletes despite high return-to-sport rates 6 months after medial patellofemoral ligament reconstruction without repeat instability.
“These findings suggest that our commonly cited ACL benchmark does not apply directly to our MPFL population and highlights the need for population-specific criteria that would help guide our rehab and return to sport discussion,” Adam J. Tagliero, MD, the associate program director for the Mayo Clinic Sports Medicine Fellowship, said in his presentation at the Arthroscopy Association

People should begin taking proactive steps to protect their brain health at or before age 40 years, according to more than 60% of U.S. adults who took part in a survey from the Ohio State University Wexner Medical Center.
In a poll of 1,004 adults (51% women), 37.5% of respondents said adults should begin taking steps to protect brain health before age 30 years while 23.8% said they should start taking steps from age 30 to 40 years, according to Douglas Scharre, MD, medical director of the Center for Cognitive and Memory Disorders at the Ohio State University Wexner Medical Center.
Scharre said

The FDA granted priority review designation to a new drug application for tinlarebant, a potential treatment for Stargardt disease type 1, according to a press release from Belite Bio.
The oral therapy, which is designed to reduce the accumulation of vitamin A-based toxins that contribute to the progression of retinal diseases, was assigned a Prescription Drug User Fee Act date of Feb. 12, 2027. The designation was supported by results from the phase 3 DRAGON trial, which reported a 35.7% reduction in the growth rate of atrophic retinal lesions with tinlarebant vs. placebo, as Healio

Sunir J. Garg, MD, FACS, FASRS, spoke about TH103, a novel biologic targeting both VEGF and heparan sulfate proteoglycans, in treatment-naive patients with wet age-related macular degeneration in this video interview.
Results from the phase 1 single ascending dose study of TH103 (Kalaris Therapeutics) were presented at the American Society of Retina Specialists annual meeting.
“There’s a lot of potential here, but obviously more work needs to be done,” Garg, chief of the retina service of Wills Eye Hospital and professor of ophthalmology at Thomas Jefferson University, told Healio.